{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T23:54:26Z","timestamp":1785196466845,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,20]]},"DOI":"10.7759\/cureus.99733","type":"journal-article","created":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T01:16:49Z","timestamp":1766279809000},"source":"Crossref","is-referenced-by-count":1,"title":["The Safety of Nebulized Conjugated Linoleic Acid for COVID-19 Respiratory Tract Infections"],"prefix":"10.7759","author":[{"given":"Sven T","family":"Jonsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J","family":"Beckworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1080\/10408398.2010.501409","article-title":"Implication of conjugated linoleic acid (CLA) in human health","volume":"52","author":"Dilzer A","year":"2012","unstructured":"Dilzer A, Park Y. Implication of conjugated linoleic acid (CLA) in human health. Crit Rev Food Sci Nutr. 2012, 52:488-513. 10.1080\/10408398.2010.501409","journal-title":"Crit Rev Food Sci Nutr"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/s0163-7827(01)00008-x","article-title":"The biologically active isomers of conjugated linoleic acid","volume":"40","author":"Pariza MW","year":"2001","unstructured":"Pariza MW, Park Y, Cook ME. The biologically active isomers of conjugated linoleic acid. Prog Lipid Res. 2001, 40:283-98. 10.1016\/s0163-7827(01)00008-x","journal-title":"Prog Lipid Res"},{"key":"ref3","unstructured":"Conjugated linoleic acid isomers. (2025). Accessed. September 10, 2025: https:\/\/hfpappexternal.fda.gov\/scripts\/fdcc\/index.cfm?set=GRASNotices&id=232."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1128\/EC.00305-10","article-title":"Conjugated linoleic acid inhibits hyphal growth in Candida albicans by modulating Ras1p cellular levels and downregulating TEC1 expression","volume":"10","author":"Shareck J","year":"2011","unstructured":"Shareck J, Nantel A, Belhumeur P. Conjugated linoleic acid inhibits hyphal growth in Candida albicans by modulating Ras1p cellular levels and downregulating TEC1 expression. Eukaryot Cell. 2011, 10:565-77. 10.1128\/EC.00305-10","journal-title":"Eukaryot Cell"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/133.10.3204","article-title":"Conjugated linoleic acid ameliorates viral infectivity in a pig model of virally induced immunosuppression","volume":"133","author":"Bassaganya-Riera J","year":"2003","unstructured":"Bassaganya-Riera J, Pogranichniy RM, Jobgen SC, et al.. Conjugated linoleic acid ameliorates viral infectivity in a pig model of virally induced immunosuppression. J Nutr. 2003, 133:3204-14. 10.1093\/jn\/133.10.3204","journal-title":"J Nutr"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.apjtm.2016.01.021","article-title":"Evaluation of anti-tubercular activity of linolenic acid and conjugated-linoleic acid as effective inhibitors against Mycobacterium tuberculosis","volume":"9","author":"Choi WH","year":"2016","unstructured":"Choi WH. Evaluation of anti-tubercular activity of linolenic acid and conjugated-linoleic acid as effective inhibitors against Mycobacterium tuberculosis. Asian Pac J Trop Med. 2016, 9:125-9. 10.1016\/j.apjtm.2016.01.021","journal-title":"Asian Pac J Trop Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.rvsc.2014.12.007","article-title":"Dietary conjugated linoleic acid and its effect on immune response in pigs infected with the porcine reproductive and respiratory syndrome virus","volume":"98","author":"Pinelli-Saavedra A","year":"2015","unstructured":"Pinelli-Saavedra A, Peralta-Quintana JR, Sosa-Casta\u00f1eda J, Moya-Camarena SY, Burgara-Estrella A, Hern\u00e1ndez J. Dietary conjugated linoleic acid and its effect on immune response in pigs infected with the porcine reproductive and respiratory syndrome virus. Res Vet Sci. 2015, 98:30-8. 10.1016\/j.rvsc.2014.12.007","journal-title":"Res Vet Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.psj.2023.103167","article-title":"Cellular and humoral immunity of broilers subjected to posthatch fasting and a prestarter diet containing conjugated linoleic acid","volume":"102","author":"Martins PC","year":"2023","unstructured":"Martins PC, Santos JS, Rezende PM, et al.. Cellular and humoral immunity of broilers subjected to posthatch fasting and a prestarter diet containing conjugated linoleic acid. Poult Sci. 2023, 102:103167. 10.1016\/j.psj.2023.103167","journal-title":"Poult Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.22851","article-title":"Potassium linoleate (isomerized) satisfies the United States Environmental Protection Agency MB-05-16 for hospital disinfectant on hard, non-porous surfaces","volume":"14","author":"Changaris DG","year":"2022","unstructured":"Changaris DG, Carenbauer AL. Potassium linoleate (isomerized) satisfies the United States Environmental Protection Agency MB-05-16 for hospital disinfectant on hard, non-porous surfaces. Cureus. 2022, 14:e22851. 10.7759\/cureus.22851","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s11745-006-5048-z","article-title":"Fatty acids and monoacylglycerols inhibit growth of Staphylococcus aureus","volume":"41","author":"Kelsey JA","year":"2006","unstructured":"Kelsey JA, Bayles KW, Shafii B, McGuire MA. Fatty acids and monoacylglycerols inhibit growth of Staphylococcus aureus. Lipids. 2006, 41:951-61. 10.1007\/s11745-006-5048-z","journal-title":"Lipids"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd3255","article-title":"Free fatty acid binding pocket in the locked structure of SARS-CoV-2 spike protein","volume":"370","author":"Toelzer C","year":"2020","unstructured":"Toelzer C, Gupta K, Yadav SK, et al.. Free fatty acid binding pocket in the locked structure of SARS-CoV-2 spike protein. Science. 2020, 370:725-30. 10.1126\/science.abd3255","journal-title":"Science"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/jmcb\/mjad021","article-title":"SARS-CoV-2 spike variants differ in their allosteric responses to linoleic acid","volume":"15","author":"Oliveira AS","year":"2023","unstructured":"Oliveira AS, Shoemark DK, Davidson AD, Berger I, Schaffitzel C, Mulholland AJ. SARS-CoV-2 spike variants differ in their allosteric responses to linoleic acid. J Mol Cell Biol. 2023, 15:mjad021. 10.1093\/jmcb\/mjad021","journal-title":"J Mol Cell Biol"},{"key":"ref13","article-title":"Case study using nebulized isomerized linoleic acid (LA) for outpatient treatment of symptomatic COVID-19 [PREPRINT]","author":"Jonsson S","year":"2020","unstructured":"Jonsson S, Mendenhall M, and Jonsson C. Case study using nebulized isomerized linoleic acid (LA) for outpatient treatment of symptomatic COVID-19 [PREPRINT]. Europe PMS. 2020,","journal-title":"Europe PMS"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6930e1","article-title":"Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a Multistate Health Care Systems Network - United States, March-June 2020","volume":"69","author":"Tenforde MW","year":"2020","unstructured":"Tenforde MW, Kim SS, Lindsell CJ, et al.. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a Multistate Health Care Systems Network - United States, March-June 2020. Morb Mortal Wkly Rep. 2020, 69:993-8. 10.15585\/mmwr.mm6930e1","journal-title":"Morb Mortal Wkly Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa286","article-title":"The course of mild and moderate COVID-19 infections-the unexpected long-lasting challenge","volume":"7","author":"Xia L","year":"2020","unstructured":"Xia L, Chen J, Friedemann T, et al.. The course of mild and moderate COVID-19 infections-the unexpected long-lasting challenge. Open Forum Infect Dis. 2020, 7:ofaa286. 10.1093\/ofid\/ofaa286","journal-title":"Open Forum Infect Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/79.6.1118","article-title":"Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans","volume":"79","author":"Gaullier JM","year":"2004","unstructured":"Gaullier JM, Halse J, H\u00f8ye K, Kristiansen K, Fagertun H, Vik H, Gudmundsen O. Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans. Am J Clin Nutr. 2004, 79:1118-25. 10.1093\/ajcn\/79.6.1118","journal-title":"Am J Clin Nutr"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2004.06.008","article-title":"Safety profile of conjugated linoleic acid in a 12-month trial in obese humans","volume":"42","author":"Whigham LD","year":"2004","unstructured":"Whigham LD, O'Shea M, Mohede IC, Walaski HP, Atkinson RL. Safety profile of conjugated linoleic acid in a 12-month trial in obese humans. Food Chem Toxicol. 2004, 42:1701-9. 10.1016\/j.fct.2004.06.008","journal-title":"Food Chem Toxicol"},{"key":"ref18","article-title":"Adverse effects of conjugated linoleic acids supplementation on circulating lipoprotein (a) levels in overweight and obese individuals: results of a systematic review and meta-analysis of randomized controlled trials","volume":"11","author":"Leilami K","year":"2021","unstructured":"Leilami K, Kohansal A, Mohammadi Sartang M, Babajafari S, Sohrabi Z. Adverse effects of conjugated linoleic acids supplementation on circulating lipoprotein (a) levels in overweight and obese individuals: results of a systematic review and meta-analysis of randomized controlled trials. Am J Cardiovasc Dis. 2021, 11:124-35.","journal-title":"Am J Cardiovasc Dis"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.R300011-JLR200","article-title":"Efficacy and safety of dietary supplements containing CLA for the treatment of obesity: evidence from animal and human studies","volume":"44","author":"Larsen TM","year":"2003","unstructured":"Larsen TM, Toubro S, Astrup A. Efficacy and safety of dietary supplements containing CLA for the treatment of obesity: evidence from animal and human studies. J Lipid Res. 2003, 44:2234-41. 10.1194\/jlr.R300011-JLR200","journal-title":"J Lipid Res"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1021\/jf8031167","article-title":"Growth inhibition of foodborne and pathogenic bacteria by conjugated linoleic acid","volume":"57","author":"Byeon JI","year":"2009","unstructured":"Byeon JI, Song HS, Oh TW, et al.. Growth inhibition of foodborne and pathogenic bacteria by conjugated linoleic acid. J Agric Food Chem. 2009, 57:3164-72. 10.1021\/jf8031167","journal-title":"J Agric Food Chem"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1128\/JB.00743-12","article-title":"Membrane disruption by antimicrobial fatty acids releases low-molecular-weight proteins from Staphylococcus aureus","volume":"194","author":"Parsons JB","year":"2012","unstructured":"Parsons JB, Yao J, Frank MW, Jackson P, Rock CO. Membrane disruption by antimicrobial fatty acids releases low-molecular-weight proteins from Staphylococcus aureus. J Bacteriol. 2012, 194:5294-304. 10.1128\/JB.00743-12","journal-title":"J Bacteriol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2021.101093","article-title":"Antibacterial fatty acids: an update of possible mechanisms of action and implications in the development of the next-generation of antibacterial agents","volume":"82","author":"Casillas-Vargas G","year":"2021","unstructured":"Casillas-Vargas G, Ocasio-Malav\u00e9 C, Medina S, Morales-Guzm\u00e1n C, Del Valle RG, Carballeira NM, Sanabria-R\u00edos DJ. Antibacterial fatty acids: an update of possible mechanisms of action and implications in the development of the next-generation of antibacterial agents. Prog Lipid Res. 2021, 82:101093. 10.1016\/j.plipres.2021.101093","journal-title":"Prog Lipid Res"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2022.11.007","article-title":"Pathophysiology of hypoxemia in COVID-19 lung disease","volume":"44","author":"Swenson KE","year":"2023","unstructured":"Swenson KE, Hardin CC. Pathophysiology of hypoxemia in COVID-19 lung disease. Clin Chest Med. 2023, 44:239-48. 10.1016\/j.ccm.2022.11.007","journal-title":"Clin Chest Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202111-2606OC","article-title":"Prevalence and mechanisms of mucus accumulation in COVID-19 lung disease","volume":"206","author":"Kato T","year":"2022","unstructured":"Kato T, Asakura T, Edwards CE, et al.. Prevalence and mechanisms of mucus accumulation in COVID-19 lung disease. Am J Respir Crit Care Med. 2022, 206:1336-52. 10.1164\/rccm.202111-2606OC","journal-title":"Am J Respir Crit Care Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-00435-z","article-title":"Mucus production stimulated by IFN-AhR signaling triggers hypoxia of COVID-19","volume":"30","author":"Liu Y","year":"2020","unstructured":"Liu Y, Lv J, Liu J, et al.. Mucus production stimulated by IFN-AhR signaling triggers hypoxia of COVID-19. Cell Res. 2020, 30:1078-87. 10.1038\/s41422-020-00435-z","journal-title":"Cell Res"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202004-0945LE","article-title":"Bronchoscopy in patients with COVID-19 with invasive mechanical ventilation: a single-center experience","volume":"202","author":"Torrego A","year":"2020","unstructured":"Torrego A, Pajares V, Fern\u00e1ndez-Arias C, Vera P, Mancebo J. Bronchoscopy in patients with COVID-19 with invasive mechanical ventilation: a single-center experience. Am J Respir Crit Care Med. 2020, 202:284-7. 10.1164\/rccm.202004-0945LE","journal-title":"Am J Respir Crit Care Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2020.110081","article-title":"Surfactant-based prophylaxis and therapy against COVID-19: a possibility","volume":"143","author":"Pramod K","year":"2020","unstructured":"Pramod K, Kotta S, Jijith US, Aravind A, Abu Tahir M, Manju CS, Gangadharappa HV. Surfactant-based prophylaxis and therapy against COVID-19: a possibility. Med Hypotheses. 2020, 143:110081. 10.1016\/j.mehy.2020.110081","journal-title":"Med Hypotheses"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1177\/088532820001400304","article-title":"Exogenous surfactant therapy and mucus rheology in chronic obstructive airway diseases","volume":"14","author":"Banerjee R","year":"2000","unstructured":"Banerjee R, Puniyani RR. Exogenous surfactant therapy and mucus rheology in chronic obstructive airway diseases. J Biomater Appl. 2000, 14:243-72. 10.1177\/088532820001400304","journal-title":"J Biomater Appl"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2011.00012","article-title":"Long-term colonization of the cystic fibrosis lung by Burkholderia cepacia complex bacteria: epidemiology, clonal variation, and genome-wide expression alterations","volume":"1","author":"Coutinho CP","year":"2011","unstructured":"Coutinho CP, Dos Santos SC, Madeira A, Mira NP, Moreira AS, S\u00e1-Correia I. Long-term colonization of the cystic fibrosis lung by Burkholderia cepacia complex bacteria: epidemiology, clonal variation, and genome-wide expression alterations. Front Cell Infect Microbiol. 2011, 1:12. 10.3389\/fcimb.2011.00012","journal-title":"Front Cell Infect Microbiol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2105482118","article-title":"Intensity and frequency of extreme novel epidemics","volume":"118","author":"Marani M","year":"2021","unstructured":"Marani M, Katul GG, Pan WK, Parolari AJ. Intensity and frequency of extreme novel epidemics. Proc Natl Acad Sci. 2021, 118:e2105482118. 10.1073\/pnas.2105482118","journal-title":"Proc Natl Acad Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/437165-the-safety-of-nebulized-conjugated-linoleic-acid-for-covid-19-respiratory-tract-infections","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T01:16:50Z","timestamp":1766279810000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/437165-the-safety-of-nebulized-conjugated-linoleic-acid-for-covid-19-respiratory-tract-infections"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,20]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.99733","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,20]]}}}